| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/06/2009 | CN100484957C Thymosin beta4 derivative and its use |
| 05/06/2009 | CN100484956C Compound from catarrh mollase bacterial |
| 05/06/2009 | CN100484954C Method for purifying drug active protein by cation exchange chromatogrphy |
| 05/06/2009 | CN100484568C Antibiosis usage of a family of protein |
| 05/06/2009 | CN100484495C Mouse asthmatic model semiotic monitor |
| 05/05/2009 | US7528306 Soybean variety 4282159 |
| 05/05/2009 | US7528296 Transgenic plant with a plant transformation vector comprising a nucleotide sequence encoding a HIO32.3 polypeptide; a high oil content phenotype |
| 05/05/2009 | US7528245 Expression control sequence cassette; a nucleotide sequence of a lac operator sequence to which a lacI repressor protein specifically binds a mutated lac; modification of the nucleotide sequence within a T5 promoter/lac operator expression control sequence provides a stable promoter/operator |
| 05/05/2009 | US7528244 Protein for use in the diagnosis and treatment of cell death defects |
| 05/05/2009 | US7528242 Methods and compositions comprising Renilla GFP |
| 05/05/2009 | US7528238 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26) |
| 05/05/2009 | US7528234 Conjugating doxorubicin (6-maleimidocaproyl)hydrazone with lactosaminated albumin in the presence of tris(2-carboxyethyl)phosphine reducing agent |
| 05/05/2009 | US7528233 covalent heterodimer of two different neurotrophins; which have multiple neurotrophic specificities; use in treatment of nervous system disorders |
| 05/05/2009 | US7528232 Utility of phylloplanins as antibiotics, selective fungicides and for enhancing microbial resistance in crop plants |
| 05/05/2009 | US7528231 Kv10.1, a novel voltage-gated potassium channel from human brain |
| 05/05/2009 | US7528230 Signaling polypeptide for use as reporter molecule in biosensing system |
| 05/05/2009 | US7528229 Isolated human and rat GAL-R2 galanin receptors |
| 05/05/2009 | US7528226 TGFβ1-inhibitor peptides |
| 05/05/2009 | US7528225 Peptide fragment with immunogenic or therapeutic properties against ischemic cardiovascular diseases |
| 05/05/2009 | US7528224 Human Leucocyte antigen-A2 binding peptide having an amino acid sequence from a signal peptide encoded by the MUC-1 gene; immune reaction against tumor cells further increased by the simultaneous use of cytotoxic T cells directed against both peptides presented by MHC-1 molecules. |
| 05/05/2009 | US7528223 Polypeptide encoded by an alternative reading frame of an influenza virus |
| 05/05/2009 | US7528116 Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis |
| 05/05/2009 | US7528112 Small survival-promoting/immunomodulatory peptide for treatment of brain damage, neurodegenerative disorders, and inflammatory disorders |
| 05/05/2009 | US7528111 Method of vaccinating subjects receiving immune modulating therapy |
| 05/05/2009 | US7528110 Anti-allergic complex molecules |
| 05/05/2009 | US7528109 Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders |
| 05/05/2009 | US7528106 Angiostatic fragment of tryptophanyl-tRNA synthetase (TrpRS) and vascular endothelial growth factor (VEGF) signaling inhibitor and an integrin signaling inhibitor; peptide, pegaptanib sodium, EMD 472523; antiangiogenic drugs |
| 05/05/2009 | US7528105 Heterodimeric chain synthetic heparin-binding growth factor analogs |
| 05/05/2009 | US7528104 Peptides that bind to the erythropoietin receptor |
| 05/05/2009 | US7528093 Using genetic rearrangement in genomic region associated with brain voltage-gated sodium channel to detect convulsive disorder |
| 05/05/2009 | US7527969 Comprises purified imunoglobulin polypeptide or antigen binding fragment for diagnosis of disease/cancer |
| 05/05/2009 | US7527967 Recombinant baculovirus and virus-like particle |
| 05/05/2009 | US7527966 Expression vector comprising kinase nucleotide sequence for use as tool in transformation and expression of heterologus genes in mamalian cells |
| 05/05/2009 | US7527954 Compartmentalisation of nucleic acids together with an in vitro transcription-translation mixture in a water-in-oil emulsion, the expression of fusion polypeptides coded by the nucleic acids; fusion polypeptides are covalently bonded to the nucleic acid coding for the fusion polypeptide |
| 05/05/2009 | US7527950 Ability to produce L-glutamic acid, valine, threaonine, histidine or proline is incrreased by increasing expression of a specific protein, e.g., by increasing the copy number of the DNA coding for the protein |
| 05/05/2009 | US7527946 Angiogenesis and neovascularization inhibition; host cells, recombinant DNA; increased half life and longer vasculature retention time |
| 05/05/2009 | US7527944 Taste receptors of the T1R family from domestic cat |
| 05/05/2009 | US7527937 Providing a protein having a function as a G-protein coupled receptor; drug screening for antidepressants; gene encoding a G-protein coupled receptor for which cholecystokinin octapeptide sulfated form |
| 05/05/2009 | US7527935 G-protein coupled receptor having eicosanoid as ligand and gene thereof |
| 05/05/2009 | US7527933 Genetic products differentially expressed in tumors and the use thereof |
| 05/05/2009 | US7527925 Purified pol DNA, a recombinant DNA construct for expression of HIV pol polypeptide sequences and a cell containing such construct |
| 05/05/2009 | US7527810 Oral immunology using plant product containing hepatitis surface antigen |
| 05/05/2009 | US7527800 Influenza hemagglutinin and neuraminidase variants |
| 05/05/2009 | US7527798 Composition and method for preventing or treating a virus infection |
| 05/05/2009 | US7527796 Constructing recombinant gene encoding immunoglobulin fusion for use in diagnosis, prevention and treatment of equine viral disease; veterinary medicine |
| 05/05/2009 | US7527795 Peptide epitopes of apolipoprotein B |
| 05/05/2009 | US7527794 Nucleotide sequences coding immunoglobulin fusion specific to heparan sulfate proteoglycans for use as diagnostic and therapeutic tool in treatment and prevention of neurodegenerative and cell proliferative disorders |
| 05/05/2009 | US7527793 Immunogenic peptides |
| 05/05/2009 | US7527790 Genetic engineered protein; screening, controlling gene expression |
| 05/05/2009 | US7527788 Purified antibody, monoclonal antibody, or polyclonal antibody that binds to DES protein of Mycobacterium tuberculosis; medical diagnosis |
| 05/05/2009 | US7527786 Monoclonal anti-idiotypic antibody; antitumor agents; anticarcinogenic agents; antiproliferative agents; immunotherapy; hormone antagonist therapy |
| 05/05/2009 | CA2610100A1 Methods and compositions for treating and preventing malaria |
| 05/05/2009 | CA2606624A1 Methods and compositions for treating and preventing malaria (2) |
| 05/05/2009 | CA2280931C Matrix-free osteogenic devices, implants and methods of use thereof |
| 05/05/2009 | CA2253790C Methods of enhancing anti-tumour immunity in a mammal |
| 05/05/2009 | CA2234980C Cyclopeptide derivatives |
| 05/05/2009 | CA2173338C Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 05/05/2009 | CA2149298C Flk-1 is a receptor for vascular endothelial growth factor |
| 05/01/2009 | CA2607771A1 Humanized anti-venezuelan equine encephalitis virus recombinant antibody |
| 05/01/2009 | CA2606828A1 Methods of assessing and treating pulmonary disease |
| 04/30/2009 | WO2009055697A1 Chimeric phage tail proteins and uses thereof |
| 04/30/2009 | WO2009055653A1 Pegylation by the dock and lock (dnl) technique |
| 04/30/2009 | WO2009055538A1 Oxidant resistant apolipoprotein a-1 and mimetic peptides |
| 04/30/2009 | WO2009055534A1 Regulatory elements associated with cbf transcription factor of rye |
| 04/30/2009 | WO2009055512A2 Methods and compostions for obtaining high-resolution crystals of membrane proteins |
| 04/30/2009 | WO2009055491A2 Respiratory syncytial virus vaccine based on chimeric papillomavirus virus-like particles or capsomeres |
| 04/30/2009 | WO2009055454A2 Xylan-utilization regulon for efficient bioprocessing of hemicellulose and uses thereof |
| 04/30/2009 | WO2009055421A1 Chimeric c3-like rho antagonist cardiac therapeutic |
| 04/30/2009 | WO2009055417A1 Compositions for detecting antibodies to babesia microti and methods of uses thereof |
| 04/30/2009 | WO2009055111A2 Human laminin receptor crystal and uses thereof |
| 04/30/2009 | WO2009055068A1 Streptavidin macromolecular adaptor and complexes thereof |
| 04/30/2009 | WO2009054754A1 PHINS21 RECOMBINANT PLASMID FOR ENCODING HYBRID PROTEIN WITH HUMAN PROINSULIN, AN Escherichia coli JM109/pHINS21 BACTERIA STRAIN AS A PRODUCER OF HYBRID PROTEIN WITH HUMAN PROINSULIN AND A HUMAN PROINSULIN PRODUCING METHOD |
| 04/30/2009 | WO2009054537A1 PEPTIDE VACCINE USING MIMIC MOLECULE OF AMYLOID β-PEPTIDE |
| 04/30/2009 | WO2009054321A1 IMMUNOGLOBULIN IgA CLASS SWITCHING AGENT |
| 04/30/2009 | WO2009054128A1 Method for efficient production of monocyte-derived multipotent cell (momc) |
| 04/30/2009 | WO2009053985A1 Methods of processing recombinant procollagen |
| 04/30/2009 | WO2009053967A1 Stable amorphous calcium carbonate comprising phosphorylated amino acids, synthetic phosphorylated peptides, and gastrolith proteins |
| 04/30/2009 | WO2009053844A1 Synthetic antigenic peptides and lipopeptides derived fro mycobacterium avium subsp. paratuberculosis |
| 04/30/2009 | WO2009053723A1 Small protective epitopes of the yersinia pestis v antigen and dna vaccines encoding these |
| 04/30/2009 | WO2009053683A2 Treatment of inflammatory diseases |
| 04/30/2009 | WO2009053637A2 Anti-ricin antibody |
| 04/30/2009 | WO2009053536A2 Splice variants of gdnf and uses thereof |
| 04/30/2009 | WO2009053535A2 Peptide vaccine for influenza virus |
| 04/30/2009 | WO2009053523A1 A new biomarker for monitoring development of diseases and assessing the efficacy of therapies |
| 04/30/2009 | WO2009053512A1 Porcine torovirus proteins n, m and he, method for production thereof and uses thereof in diagnosis and treatment of porcine torovirus |
| 04/30/2009 | WO2009053368A1 Single ifn-beta fused to a mutated igg fc fragment |
| 04/30/2009 | WO2009053358A1 Method for purifying fc-fusion proteins |
| 04/30/2009 | WO2009053354A1 Use of tenascin-w as a biomarker for colon cancer |
| 04/30/2009 | WO2009053340A1 New antiviral peptides prom african swine fever virus which prevent the binding of the virus to dlc8 |
| 04/30/2009 | WO2009053315A1 Insulinotropic peptide synthesis using solid and solution phase combination techniques |
| 04/30/2009 | WO2009053064A1 Sdf-1-based glycosaminoglycan antagonists and methods of using same |
| 04/30/2009 | WO2009053041A2 Identification of tumor-associated markers for diagnosis and therapy |
| 04/30/2009 | WO2009052971A1 Complexes of trpc domains and sestd1 domains and methods and uses involving the same |
| 04/30/2009 | WO2009052687A1 Genes for improving salt tolerance and drought tolerance of plant and the uses thereof |
| 04/30/2009 | WO2009052628A1 Antibodies against a cancer-associated epitope of variant hnrnpg and uses thereof |
| 04/30/2009 | WO2009052623A1 Therapeutic and diagnostic methods using tim-3 |
| 04/30/2009 | WO2009052588A1 Cytokine muteins |
| 04/30/2009 | WO2009052572A1 Streptococcus m protein, immunogenic fragments, nucleic acids and methods of use |
| 04/30/2009 | WO2009052555A1 Immunogenic protein pas n 1 from bahia grass pollen |
| 04/30/2009 | WO2009036460A3 Modified human apolipoprotein a-i polypeptides and their uses |